NEW YORK (GenomeWeb News) – Quebec's government will provide C$10 million (US$9.9 million) over four years to launch a new personalized cancer medicine collaboration between private and public partners that will aim to integrate biomarkers into cancer care and reduce treatment costs.

The new Personalized Medicine Partnership for Cancer also will raise C$11.1 million from private-sector partners, and it will be led by the Montreal-based protein biomarker developer Caprion Proteome, according to the partners in the effort.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.